Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
296 | 3 | VASC SURG//JOURNAL OF VASCULAR SURGERY//ABDOMINAL AORTIC ANEURYSM | 41838 |
2035 | 2 | PERIPHERAL ARTERIAL DISEASE//ANKLE BRACHIAL INDEX//INTERMITTENT CLAUDICATION | 5796 |
16094 | 1 | CILOSTAZOL//TRIPLE ANTIPLATELET THERAPY//CLIN PHARMACOKINET PHARMACODYNAM METAB | 700 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CILOSTAZOL | authKW | 10200676 | 51% | 63% | 360 |
2 | TRIPLE ANTIPLATELET THERAPY | authKW | 363177 | 2% | 73% | 11 |
3 | CLIN PHARMACOKINET PHARMACODYNAM METAB | address | 331527 | 1% | 82% | 9 |
4 | PHOSPHODIESTERASE 3 INHIBITOR | authKW | 166738 | 1% | 37% | 10 |
5 | CAS 73963 72 1 | authKW | 144071 | 1% | 80% | 4 |
6 | MED I EM TISSUE REGENERAT | address | 107691 | 2% | 15% | 16 |
7 | OPC 13013 | authKW | 101300 | 0% | 75% | 3 |
8 | CILOSTAZOL THERAPY | authKW | 90045 | 0% | 100% | 2 |
9 | NSP 513 | authKW | 90045 | 0% | 100% | 2 |
10 | PLETAALR | authKW | 90045 | 0% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 3632 | 21% | 0% | 150 |
2 | Cardiac & Cardiovascular System | 1833 | 21% | 0% | 146 |
3 | Pharmacology & Pharmacy | 1821 | 31% | 0% | 216 |
4 | Hematology | 244 | 6% | 0% | 45 |
5 | Chemistry, Medicinal | 166 | 5% | 0% | 37 |
6 | Neurosciences | 126 | 10% | 0% | 72 |
7 | Medicine, Research & Experimental | 96 | 6% | 0% | 39 |
8 | Surgery | 94 | 8% | 0% | 59 |
9 | Clinical Neurology | 63 | 6% | 0% | 40 |
10 | Endocrinology & Metabolism | 43 | 4% | 0% | 30 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLIN PHARMACOKINET PHARMACODYNAM METAB | 331527 | 1% | 82% | 9 |
2 | MED I EM TISSUE REGENERAT | 107691 | 2% | 15% | 16 |
3 | NEW DRUG DISCOVERY 1 | 56555 | 1% | 18% | 7 |
4 | ADV PHARMACOL | 50647 | 0% | 38% | 3 |
5 | MERIDIAN STRUCT MED | 45459 | 1% | 10% | 10 |
6 | ANAESTHESIA REANIMATON | 45023 | 0% | 100% | 1 |
7 | BEIJING HEART LUNG BLOOD VESSEL | 45023 | 0% | 100% | 1 |
8 | BEIJING MIL BRANCH | 45023 | 0% | 100% | 1 |
9 | BIOFUCT MOL | 45023 | 0% | 100% | 1 |
10 | CARDIAC CORE ANAL | 45023 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS SUPPLEMENTS | 5716 | 1% | 2% | 6 |
2 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 4706 | 3% | 1% | 21 |
3 | CIRCULATION JOURNAL | 3401 | 3% | 0% | 19 |
4 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 2412 | 1% | 1% | 8 |
5 | CARDIOVASCULAR THERAPEUTICS | 2306 | 1% | 1% | 5 |
6 | CLINICAL PHARMACOKINETICS | 1488 | 1% | 0% | 9 |
7 | THROMBOSIS RESEARCH | 1383 | 3% | 0% | 18 |
8 | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | 1354 | 1% | 0% | 9 |
9 | JOURNAL OF GERIATRIC CARDIOLOGY | 907 | 0% | 1% | 3 |
10 | ATHEROSCLEROSIS | 793 | 2% | 0% | 14 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CILOSTAZOL | 10200676 | 51% | 63% | 360 | Search CILOSTAZOL | Search CILOSTAZOL |
2 | TRIPLE ANTIPLATELET THERAPY | 363177 | 2% | 73% | 11 | Search TRIPLE+ANTIPLATELET+THERAPY | Search TRIPLE+ANTIPLATELET+THERAPY |
3 | PHOSPHODIESTERASE 3 INHIBITOR | 166738 | 1% | 37% | 10 | Search PHOSPHODIESTERASE+3+INHIBITOR | Search PHOSPHODIESTERASE+3+INHIBITOR |
4 | CAS 73963 72 1 | 144071 | 1% | 80% | 4 | Search CAS+73963+72+1 | Search CAS+73963+72+1 |
5 | OPC 13013 | 101300 | 0% | 75% | 3 | Search OPC+13013 | Search OPC+13013 |
6 | CILOSTAZOL THERAPY | 90045 | 0% | 100% | 2 | Search CILOSTAZOL+THERAPY | Search CILOSTAZOL+THERAPY |
7 | NSP 513 | 90045 | 0% | 100% | 2 | Search NSP+513 | Search NSP+513 |
8 | PLETAALR | 90045 | 0% | 100% | 2 | Search PLETAALR | Search PLETAALR |
9 | PLETAL | 90045 | 0% | 100% | 2 | Search PLETAL | Search PLETAL |
10 | PHOSPHODIESTERASE III INHIBITOR | 62627 | 1% | 17% | 8 | Search PHOSPHODIESTERASE+III+INHIBITOR | Search PHOSPHODIESTERASE+III+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |